01 1Jyseleca
02 1Jyselect
Main Therapeutic Indication : Gastrointestinal Diseases
Currency : USD
2022 Revenue in Millions : 40
2021 Revenue in Millions : 0
Growth (%) : 100
Main Therapeutic Indication : Gastrointestinal Diseases
Currency : USD
2023 Revenue in Millions : 65
2022 Revenue in Millions : 40
Growth (%) : 81
LOOKING FOR A SUPPLIER?